Načítá se...
Drug‐drug interaction of atazanavir on UGT1A1‐mediated glucuronidation of molidustat in human
Molidustat is an oral inhibitor of hypoxia‐inducible factor (HIF) prolyl‐hydroxylase enhancing the erythropoietin (EPO) response to HIF; it is in clinical development for the treatment of anaemia related to chronic kidney disease. The predominant role of glucuronidation for molidustat clearance (for...
Uloženo v:
| Vydáno v: | Basic Clin Pharmacol Toxicol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983974/ https://ncbi.nlm.nih.gov/pubmed/33232579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcpt.13538 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|